Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2024-11-25 Interim / Quarterly Rep…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Financial Results for the Half Year to 30 September 2024 58 pages 5.7MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'AUDITED FINANCIAL RESULTS FOR THE SIX MONTHS TO 30 SEPTEMBER 2024' and contains detailed financial data and performance highlights for the half-year period ending 30 September 2024. It includes operating revenue, test volumes, net loss, cash position, strategic progress, and outlook. The length is about 15,000 characters, indicating a comprehensive report rather than a brief announcement. The content includes substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. There is no indication that this is merely an announcement of a report or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2024-11-25 English
Correction - HY25 Statements Unaudited 59 pages 5.1MB
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial report covering the six months ended 30 September 2024, including financial results, strategic highlights, operational metrics, and outlook. It contains substantive financial data such as revenue, net loss, cash position, test volumes, and average sales price. The document also includes management commentary and strategic progress updates. The length is substantial (15,000 characters), and it is not merely an announcement or a brief summary. The document explicitly states it is unaudited financial results for the half-year period, which aligns with an Interim / Quarterly Report. There is no indication that this is an Annual Report (10-K) or a full audit report (AR). It is not a press release announcing a report publication but the report itself. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2025
2024-11-25 English
Interim Financial Result to be Announced 26 November 2024
Report Publication Announcement Classification · 95% confidence The document is a short announcement dated 6 November 2024, stating that the company's interim financial results for the six months ending 30 September 2024 will be released on 26 November 2024. It also mentions an investor and analyst conference call to follow the release. The document does not contain any actual financial data or detailed financial statements; it is merely an announcement of the upcoming interim results and related conference call. The document length is only 2497 characters, which is quite short and consistent with an announcement rather than a full report. According to the rules, such a document is classified as a Report Publication Announcement (RPA) because it announces the timing of a report release but does not contain the report itself.
2024-11-05 English
Interim Financial Result to be Announced 26 November 2024 1
Report Publication Announcement Classification · 95% confidence The document is a short announcement dated 6 November 2024 from Pacific Edge regarding the upcoming release of its half year financial results for the six months ending 30 September 2024. It states the results will be announced on 26 November 2024 and includes details about an investor and analyst conference call. The document does not contain any actual financial data or detailed financial statements, but rather informs about the timing and logistics of the interim results announcement and related conference call. The document length is only 2497 characters, which is quite short and consistent with an announcement rather than a full report. According to the rules, such a document announcing the release of an interim/quarterly report and conference call is best classified as a Report Publication Announcement (RPA), not as the Interim/Quarterly Report (IR) itself, since it does not contain substantive financial data or analysis.
2024-11-05 English
Pacific Edge Release Quarterly Volumes for Q2 FY25
Interim / Quarterly Report Classification · 85% confidence The document is a quarterly volume update for Q2 FY25 from Pacific Edge, detailing test volumes, sales force efficiency, and regional performance. It includes specific quarterly data and operational metrics but does not contain full financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report. The document is more of an operational update with some financial context rather than a full interim report. It is not an earnings release since it lacks key financial highlights or earnings figures. Given the detailed quarterly operational data and the nature of the update, the best fit is an Interim / Quarterly Report (IR). The document length (4742 characters) is sufficient to contain substantive data, and it is not merely an announcement or a brief summary, so it is not RPA or RNS. Q2 2025
2024-10-08 English
Pacific Edge Release Quarterly Volumes for Q2 FY25 12 pages 1.1MB
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Pacific Edge regarding their quarterly test volumes for Q2 FY25, including operational updates, sales force efficiency, and clinical guideline reviews. It contains substantive financial and operational data for the quarter ending September 2024, including test volumes, sales force metrics, and regional performance. The document also includes management commentary and outlook, typical of an interim or quarterly report. It is not merely an announcement of a report or a brief summary but provides comprehensive data and analysis for the quarter. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q2 2025
2024-10-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.